Columbus, OH – According to filings with the U.S. Securities and Exchange Commission, 3Bar Biologics is raising $1,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Bruce Caldwell played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About 3Bar Biologics

3Bar Biologics is a cutting-edge biotech company that helps the agricultural value chain optimize their solutions for improving quantity and quality of crop production. 3Bar’s proprietary delivery method grows fresh microbes on-site to ensure farmers have the most viable and abundant beneficial microbes at the time of application. By partnering with innovative like-minded companies and research universities, 3Bar is delivering the highest quality and most cost-effective biological microbe solutions to drive profitability for the agriculture industry, while also reducing its dependence on synthetic chemicals.

To learn more about 3Bar Biologics, visit http://www.3barbiologics.com/

Contact:
Bruce Caldwell, Chief Executive Officer
614-271-9388
https://www.linkedin.com/in/bruce-caldwell-40171b3/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved